Roivant Sciences Ltd. (ROIV)
28.40
-0.64
(-2.22%)
USD |
NASDAQ |
Jun 10, 16:00
28.42
+0.01
(+0.04%)
After-Hours: 20:00
Roivant Sciences Shareholders Equity (Quarterly) : 4.527B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.527B |
| December 31, 2025 | 4.269B |
| September 30, 2025 | 4.362B |
| June 30, 2025 | 4.346B |
| March 31, 2025 | 4.688B |
| December 31, 2024 | 5.189B |
| September 30, 2024 | 5.153B |
| June 30, 2024 | 5.435B |
| March 31, 2024 | 5.969B |
| December 31, 2023 | 6.090B |
| September 30, 2023 | 948.53M |
| June 30, 2023 | 910.73M |
| March 31, 2023 | 1.158B |
| Date | Value |
|---|---|
| December 31, 2022 | 955.52M |
| September 30, 2022 | 1.161B |
| June 30, 2022 | 1.384B |
| March 31, 2022 | 1.657B |
| December 31, 2021 | 1.866B |
| September 30, 2021 | 2.038B |
| June 30, 2021 | 1.823B |
| March 31, 2021 | 1.898B |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 2.032B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Centessa Pharmaceuticals Plc | 487.35M |
| Aptorum Group Ltd. | 23.12M |
| Bicycle Therapeutics Plc | 554.32M |
| Adaptimmune Therapeutics Plc | -70.96M |
| Kiniksa Pharmaceuticals International Plc | 605.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.728B |
| Total Liabilities (Quarterly) | 435.63M |
| Debt to Equity Ratio | 0.0237 |
| Current Ratio | 18.37 |
| Net Debt Paydown Yield | -0.01% |